• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

吡啶斯的明不能逆转地塞米松诱导的生长激素抑制。

Pyridostigmine does not reverse dexamethasone-induced growth hormone inhibition.

作者信息

del Balzo P, Salvatori R, Cappa M, Gertner J M

机构信息

Division of Pediatric Endocrinology, New York Hospital-Cornell University, Medical College, New York.

出版信息

Clin Endocrinol (Oxf). 1990 Nov;33(5):605-12. doi: 10.1111/j.1365-2265.1990.tb03898.x.

DOI:10.1111/j.1365-2265.1990.tb03898.x
PMID:1979261
Abstract

Glucocorticoids inhibit the growth hormone (GH) response to a variety of stimuli, including GH-releasing hormone (GHRH) in vivo, but they increase GHRH-stimulated GH secretion when added, in vitro, to animal and human pituitary cells. This discrepancy has led to the hypothesis that glucocorticoids act in vivo by increasing somatostatin secretion from the hypothalamus. To examine this hypothesis, we used a cholinergic drug, pyridostigmine (PD), which reduces hypothalamic somatostatin secretion. Eight normal volunteers were studied. They underwent four tests: (1) GHRH test; (2) Dex + GHRH (GHRH test after treatment the night before, with dexamethasone (Dex)); (3) PD + GHRH; (4) Dex + PD + GHRH. Dex significantly inhibited the GH response to GHRH expressed as area under the GH/time curve (AUC, microgram/1/min) (mean +/- SEM = 895.2 +/- 196.6 vs 1970.9 +/- 600.1, P less than 0.05). PD significantly increased the AUC of GH secretion in PD + GHRH compared with GHRH alone (3541.2 +/- 571.3 vs 1970.9 +/- 600.1, P less than 0.01) but by no means restored completely the normal GH response to GHRH, when given to Dex-pretreated subjects. Furthermore, the mean AUC of Dex + PD + GHRH was significantly lower than that of PD + GHRH (1621.7 +/- 500.6 vs 3541.2 +/- 571.3, P less than 0.01), demonstrating that Dex continues to exert its inhibitory effect on GH secretion in the presence of PD. These results suggest that glucocorticoid-induced GH inhibition does not act solely through an increase in hypothalamic somatostatin secretion.

摘要

糖皮质激素可抑制生长激素(GH)对多种刺激的反应,包括体内的生长激素释放激素(GHRH),但在体外将其添加到动物和人类垂体细胞时,它们会增加GHRH刺激的GH分泌。这种差异导致了一种假说,即糖皮质激素在体内通过增加下丘脑生长抑素的分泌起作用。为了检验这一假说,我们使用了一种胆碱能药物吡啶斯的明(PD),它可减少下丘脑生长抑素的分泌。对8名正常志愿者进行了研究。他们接受了四项测试:(1)GHRH测试;(2)地塞米松+GHRH(在前一晚用地塞米松(Dex)治疗后的GHRH测试);(3)PD+GHRH;(4)地塞米松+PD+GHRH。地塞米松显著抑制了以GH/时间曲线下面积(AUC,微克/1/分钟)表示的GH对GHRH的反应(平均值±标准误=895.2±196.6对1970.9±600.1,P<0.05)。与单独的GHRH相比,PD显著增加了PD+GHRH中GH分泌的AUC(3541.2±571.3对1970.9±600.1,P<0.01),但当给予地塞米松预处理的受试者时,绝没有完全恢复GH对GHRH的正常反应。此外,地塞米松+PD+GHRH的平均AUC显著低于PD+GHRH(1621.7±500.6对3541.2±571.3,P<0.01),表明在地塞米松存在的情况下,地塞米松继续对GH分泌发挥抑制作用。这些结果表明,糖皮质激素诱导的GH抑制并非仅通过增加下丘脑生长抑素的分泌起作用。

相似文献

1
Pyridostigmine does not reverse dexamethasone-induced growth hormone inhibition.吡啶斯的明不能逆转地塞米松诱导的生长激素抑制。
Clin Endocrinol (Oxf). 1990 Nov;33(5):605-12. doi: 10.1111/j.1365-2265.1990.tb03898.x.
2
Regulation of hypothalamic somatostatin by glucocorticoids.糖皮质激素对下丘脑生长抑素的调节
J Steroid Biochem Mol Biol. 1995 Jun;53(1-6):277-82. doi: 10.1016/0960-0760(95)00065-8.
3
Glucocorticoids may inhibit growth hormone release by enhancing beta-adrenergic responsiveness in hypothalamic somatostatin neurons.糖皮质激素可能通过增强下丘脑生长抑素神经元中的β-肾上腺素能反应性来抑制生长激素释放。
J Clin Endocrinol Metab. 1993 Feb;76(2):439-44. doi: 10.1210/jcem.76.2.8094392.
4
Pyridostigmine partially reverses dexamethasone-induced inhibition of the growth hormone response to growth hormone-releasing hormone.
J Endocrinol. 1992 Sep;134(3):513-7. doi: 10.1677/joe.0.1340513.
5
Low hexarelin dose and pyridostigmine have additive effect and potentiate to the same extent the GHRH-induced GH response in man.低剂量六氢瑞林和吡啶斯的明具有相加作用,且在同等程度上增强生长激素释放激素诱导的人体生长激素反应。
Clin Endocrinol (Oxf). 1997 Oct;47(4):495-500. doi: 10.1046/j.1365-2265.1997.3081114.x.
6
Pyridostigmine blocks the inhibitory effect of glucocorticoids on growth hormone-releasing hormone stimulated growth hormone secretion in normal man.吡啶斯的明可阻断糖皮质激素对正常人体内生长激素释放激素刺激的生长激素分泌的抑制作用。
J Clin Endocrinol Metab. 1990 Sep;71(3):580-4. doi: 10.1210/jcem-71-3-580.
7
Radiation and neuroregulatory control of growth hormone secretion.
Clin Endocrinol (Oxf). 1994 Aug;41(2):163-8. doi: 10.1111/j.1365-2265.1994.tb02525.x.
8
Activation of cholinergic neurotransmission by pyridostigmine reverses the inhibitory effect of hyperglycemia on growth hormone (GH) releasing hormone-induced GH secretion in man: does acute hyperglycemia act through hypothalamic release of somatostatin?吡啶斯的明激活胆碱能神经传递可逆转高血糖对人生长激素(GH)释放激素诱导的GH分泌的抑制作用:急性高血糖是否通过下丘脑释放生长抑素起作用?
Neuroendocrinology. 1989 May;49(5):551-4. doi: 10.1159/000125166.
9
Cholinergic control of growth hormone (GH) responses to GH-releasing hormone in insulin dependent diabetics: evidence for attenuated hypothalamic somatostatinergic tone and decreased GH autofeedback.胰岛素依赖型糖尿病患者中胆碱能对生长激素释放激素引起的生长激素反应的控制:下丘脑生长抑素能张力减弱和生长激素自身反馈降低的证据
Clin Endocrinol (Oxf). 1993 Feb;38(2):149-57. doi: 10.1111/j.1365-2265.1993.tb00987.x.
10
Effects of pyridostigmine on spontaneous and growth hormone-releasing hormone stimulated growth hormone secretion in children on daily glucocorticoid therapy after liver transplantation.吡啶斯的明对肝移植后每日接受糖皮质激素治疗的儿童自发性及生长激素释放激素刺激的生长激素分泌的影响。
Clin Endocrinol (Oxf). 1991 Dec;35(6):491-8. doi: 10.1111/j.1365-2265.1991.tb00933.x.